top of page

Built by Operators. Advised by Experience.

The Brahman Group is a life sciences and diagnostics advisory firm founded on a simple premise; that the most impactful guidance comes from those who have actually led these organizations through their hardest moments. We have run CLIA-certified laboratories, launched novel diagnostics, navigated complex reimbursement landscapes, and restructured businesses on the verge of failure. That experience is what we bring to every engagement.

Our name draws from the concept of Brahman; a state of deep awareness and understanding. It reflects our belief that the most valuable thing an advisor can offer is not a framework or a slide deck, but genuine foresight; the ability to see around corners, anticipate market dynamics, and guide leadership teams through complexity with clarity and confidence.

We work with a curated network of senior operators, clinicians, and commercial leaders across life sciences, diagnostics, and healthcare technology. This model allows us to assemble the right expertise for each engagement; without the overhead of a traditional consulting firm.

Leadership

Scott Madel, Managing Director

Scott Madel is a commercial and operational executive with more than two decades of experience scaling diagnostics and life sciences organizations across the United States and Europe. He has served in numerous leadership roles including various leadeship roles for private and public companies, President of Boston Heart Diagnostics (a Eurofins company), and CEO of multiple clinical laboratory organizations. His experience spans commercialization, reimbursement strategy, M&A, and operational transformation — and he now leverages an MBA focused on Artificial Intelligence in Healthcare from Northeastern University.

"Scott is an exceptional leader, operator and motivator of change"

– Maitland Cook, MD of The Cadogan Clinic and Genova Diagnostics Europe member of the board

"Scott is an impactful leader in corporate turnaround"

– Annemarie Watson, CEO, Covaris and former SVP of Eurofins US Clinical Diagnostics

Start a Conversation.

We work with a select number of clients at any given time. If you are navigating a commercialization challenge, considering an acquisition, or building for scale — we would like to understand your situation.

All inquiries are held in strict confidence.

bottom of page